This common question arises when patients experience side effects or seek dose adjustments
Important safety considerations include a boxed warning for risk of thyroid C-cell tumors (contraindicated in patients with personal/family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2), and risks of pancreatitis, gallbladder disease, acute kidney injury with dehydration, and diabetic retinopathy complications with semaglutide
Mok J, Adeleke MO, Brown A, et al
Giorda CB, Sacerdote C, Nada E, Marafetti L, Baldi I, Gnavi R (2015) Incretin-based therapies and acute pancreatitis risk: a systematic review and meta-analysis of observational studies
Cost Comparison: Michigan Tirzepatide Options HSA and FSA funds can generally be applied to GLP-1 prescriptions when prescribed for a qualifying medical condition, which can reduce the effective cost meaningfully if you have those accounts available
No FDA Warning Letter was found for Designer Drugs Pharmacy in the FDAs public enforcement database as of March 2026